Scientists, investors, entrepreneurs and industry leaders convened on campus to explore how collaboration can turn life-changing discoveries into solutions.
The new facility nearly doubles the university's capacity to manufacture personalized treatments for patients with cancer, genetic disorders and other serious diseases.
At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.
In an alternate world, UCLA professor Anne Andrews might be a CIA agent. But in this one, she’s a scientist breaking new ground measuring chemicals in the brain and body.